Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient`s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.
Website: inspiresleep.com



Growth: Bad revenue growth rate -8.0%, there is slowdown compared to average historical growth rates 16.5%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of -4.4%

Profitability: LTM EBITDA margin is positive, +3.9%. On average the margin is decreasing unsteadily. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.25 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 5.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 59.8% higher than minimum and 74.5% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.2x by EV / Sales multiple , the company can be 7.2% undervalued

Key Financials (Download financials)

Ticker: INSP
Share price, USD:  (0.0%)63.98
year average price 73.90  


year start price 86.07 2025-11-10

max close price 143.99 2025-12-08

min close price 40.05 2026-05-16

current price 63.98 2026-11-09
Common stocks: 28 966 119

Dividend Yield:  0.0%
FCF Yield LTM: 5.3%
EV / LTM EBITDA: 52.3x
EV / Sales: 2.0x
Margin (EBITDA LTM / Revenue): 3.9%
Fundamental value created in LTM:
Market Cap ($m): 1 853
Net Debt ($m): -75
EV (Enterprise Value): 1 778
Price to Book: 2.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-06-26seekingalpha.com

Inspire Medical Systems, Inc. (INSP) Presents at Wells Fargo 2026 MedTech Innovation Spotlight Transcript

2026-01-31businesswire.com

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

2026-01-22businesswire.com

The Law Offices of Frank R. Cruz Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors

2026-01-22zacks.com

Here's Why You Should Retain INSP Stock in Your Portfolio for Now

2026-01-12seekingalpha.com

Inspire Medical Systems, Inc. (INSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-12globenewswire.com

Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance

2026-01-04globenewswire.com

FINAL DEADLINE ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut

2026-01-04newsfilecorp.com

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026

2026-01-04globenewswire.com

INSP FINAL DEADLINE: Inspire Medical Systems, Inc. Shareholders are Reminded of the Pending Securities Fraud Lawsuit – Investors with Losses Notified to Contact BFA Law

2026-01-03globenewswire.com

INSP DEADLINE MONDAY: ROSEN, A LONGSTANDING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 5 Deadline in Securities Class Action - INSP
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-03 2025-08-04 2024-11-04 2024-08-06 2024-05-07 2023-11-07 2023-08-01 2023-05-02 2022-11-01
acceptedDate 2025-11-03 16:07:50 2025-08-04 16:16:57 2025-02-10 16:23:40 2024-11-04 16:18:24 2024-08-06 16:07:03 2024-05-07 16:07:54 2024-02-09 16:02:04 2023-11-07 16:27:48 2023-08-01 16:14:05 2023-05-02 16:06:25 2023-02-10 16:15:32 2022-11-01 16:10:49 2022-02-15 16:07:01 2021-02-23 18:22:59
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 225M 217M 803M 203M 196M 164M 625M 153M 151M 128M 408M 109M 233M 115M
costOfRevenue 32M 35M 123M 32M 30M 25M 97M 24M 24M 20M 66M 20M 33M 18M
grossProfit 193M 182M 680M 171M 166M 139M 528M 129M 127M 108M 342M 89M 200M 98M
grossProfitRatio 0.858 0.84 0.841 0.848 0.849 0.841 0.839 0.844 0.819
researchAndDevelopmentExpenses 24M 26M 114M 26M 29M 29M 117M 29M 31M 26M 69M 21M 37M 26M
generalAndAdministrativeExpenses 0 0 0 0 109M 100M 0 88M 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 23M 26M 0 26M 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 159M 160M 530M 130M 132M 126M 452M 113M 113M 102M 321M 86M 203M 128M
otherExpenses 0 0 0 0 -135 000 -60 000 0 -224 000 -61 000 17 000 0 0 0 0
operatingExpenses 183M 186M 644M 156M 161M 154M 568M 142M 143M 128M 389M 107M 240M 154M
costAndExpenses 215M 220M 767M 189M 191M 179M 665M 167M 168M 147M 455M 126M 273M 172M
interestIncome 4M 4M 23M 6M 6M 6M 21M 5M 5M 4M 5M 1M 125 000 1M
interestExpense 11 000 4000 22 000 0 0 0 0 0 0 -4M 2M 656 000 2M 2M
depreciationAndAmortization 4M 3M 7M 2M 1M 839 000 3M 5M 659 000 4M 2M 2M 1M 840 000
ebitda 17M 1M 65M 16M 6M -14M -17M -8M -17M -15M -41M -15M -39M -54M
ebitdaratio 0.077 0.005 0.08 0.033 -0.088 -0.053 -0.11 -0.119 -0.141
operatingIncome 10M -3M 36M 14M 5M -15M -40M -13M -17M -19M -48M -17M -40M -56M
operatingIncomeRatio 0.043 -0.015 0.07 0.026 -0.093 -0.088 -0.11 -0.152 -0.157
totalOtherIncomeExpensesNet 4M 984 000 22M 6M 6M 6M 20M -224 000 5M 4M 3M 593 000 -2M -880 000
incomeBeforeTax 14M -2M 58M 20M 11M -9M -20M -8M -12M -15M -44M -17M -42M -57M
incomeBeforeTaxRatio 0.06 -0.011 0.1 0.055 -0.057 -0.053 -0.078 -0.119 -0.152
incomeTaxExpense 4M 1M 5M 2M 1M 650 000 1M 340 000 214 000 216 000 613 000 246 000 72 000 115 000
netIncome 10M -4M 54M 18M 10M -10M -21M -9M -12M -15M -45M -17M -42M -57M
netIncomeRatio 0.044 -0.017 0.091 0.05 -0.061 -0.056 -0.079 -0.121 -0.154
eps 0.34 -0.12 1.8 0.62 0.33 -0.34 -0.72 -0.29 -0.41 -0.53 -1.6 -0.6 -1.54 -2.19
epsdiluted 0.34 -0.12 0.6 0.32 -0.34 -0.29 -0.41 -0.53 -0.6
weightedAverageShsOut 29M 30M 30M 30M 30M 30M 29M 29M 29M 29M 28M 28M 27M 26M
weightedAverageShsOutDil 30M 30M 31M 31M 30M 30M 29M 29M 29M 29M 28M 28M 27M 26M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-10 2024-02-09 2023-02-10 2022-02-15 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 23M 21M 3M -2M -1M
ebit 58M -20M -43M -40M -55M
nonOperatingIncomeExcludingInterest -22M -20M -5M -8000 -1M
netIncomeFromContinuingOperations 54M -21M -45M -42M -57M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 54M -21M -45M -42M -57M
epsDiluted 1.75 -0.72 -1.6 -1.54 -2.19

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-03 2025-08-04 2024-11-04 2024-08-06 2024-05-07 2023-11-07 2023-08-01 2023-05-02 2022-11-01
acceptedDate 2025-11-03 16:07:50 2025-08-04 16:16:57 2025-02-10 16:23:40 2024-11-04 16:18:24 2024-08-06 16:07:03 2024-05-07 16:07:54 2024-02-09 16:02:04 2023-11-07 16:27:48 2023-08-01 16:14:05 2023-05-02 16:06:25 2023-02-10 16:15:32 2022-11-01 16:10:49 2022-02-15 16:07:01 2021-02-23 18:22:59
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 113M 107M 150M 148M 188M 175M 186M 330M 467M 442M 442M 418M 214M 191M
shortTermInvestments 210M 194M 295M 263M 252M 266M 275M 134M 0 10M 10M 10M 0 44M
cashAndShortTermInvestments 323M 301M 446M 411M 440M 441M 460M 464M 467M 452M 451M 428M 214M 234M
netReceivables 108M 138M 93M 90M 80M 72M 90M 71M 64M 60M 61M 48M 34M 25M
inventory 142M 122M 80M 67M 59M 49M 34M 26M 21M 16M 12M 15M 17M 8M
otherCurrentAssets 14M 13M 12M 14M 29M 10M 10M 8M 9M 6M 6M 4M 0 0
totalCurrentAssets 586M 573M 631M 583M 607M 572M 594M 570M 560M 534M 530M 496M 269M 270M
propertyPlantEquipmentNet 116M 110M 95M 89M 84M 75M 63M 55M 47M 28M 24M 21M 16M 11M
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
goodwillAndIntangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
longTermInvestments 105M 110M 71M 113M 37M 38M 9M 3M 0 0 0 0 10M 0
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 898 000 9M 11M 11M 595 000 895 999 11M 12M 12M 11M 11M 11M 204 000 204 000
totalNonCurrentAssets 221M 229M 178M 214M 121M 114M 83M 70M 58M 38M 35M 32M 27M 11M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 808M 802M 808M 796M 728M 686M 677M 639M 618M 572M 565M 528M 295M 281M
accountPayables 59M 53M 39M 35M 34M 44M 39M 40M 40M 36M 27M 20M 12M 7M
shortTermDebt 2M 2M 0 0 0 0 0 0 1M 1M 0 1M 9M 0
taxPayables 0 1M 2M 2M 0 0 577 000 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 0 -1M 0 0 0 0 0
otherCurrentLiabilities 49M 37M 0 38M 32M 28M 0 30M 27M 22M 0 28M 0 0
totalCurrentLiabilities 111M 93M 89M 74M 66M 72M 78M 70M 67M 60M 61M 49M 41M 21M
longTermDebt 30M 31M 0 25M 49M 25M 0 25M 22M 7M 0 8M 16M 25M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 111 000 111 000 148 000 150 000 -24M 146 000 1M 146 000 146 000 146 000 146 000 -14M 134 000 85 000
totalNonCurrentLiabilities 30M 31M 30M 25M 25M 25M 26M 25M 22M 7M 8M 8M 25M 31M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 33M 33M 32M 25M 25M 25M 25M 25M 23M 7M 9M 9M 9M 6M
totalLiabilities 141M 124M 119M 100M 90M 97M 104M 95M 89M 67M 69M 57M 66M 51M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 29 000 29 000 30 000 30 000 30 000 30 000 30 000 29 000 29 000 29 000 29 000 29 000 27 000 27 000
retainedEarnings -283M -293M -292M -327M -346M -355M -345M -360M -352M -340M -324M -327M -279M -237M
accumulatedOtherComprehensiveIncomeLoss 639 000 396 000 536 000 2M -115 000 124 000 800 000 44 000 103 000 32 000 -86 000 -363 000 -55 000 29 000
othertotalStockholdersEquity 948M 970M 1 022M 984M 944M 904M 881M 844M 798M
totalStockholdersEquity 666M 678M 690M 697M 638M 589M 573M 544M 529M 505M 496M 470M 229M 230M
totalEquity 666M 678M 690M 697M 638M 589M 573M 544M 529M 505M 496M 470M 229M 230M
totalLiabilitiesAndStockholdersEquity 808M 802M 796M 728M 686M 639M 618M 572M 528M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 808M 802M 808M 796M 728M 686M 677M 639M 618M 572M 565M 528M 295M 281M
totalInvestments 315M 304M 366M 377M 288M 304M 284M 137M 0 10M 10M 10M 10M 44M
totalDebt 33M 33M 32M 25M 25M 25M 25M 25M 23M 7M 9M 9M 34M 31M
netDebt -80M -74M -118M -122M -164M -151M -161M -305M -444M -435M -433M -409M -180M -160M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-10 2024-02-09 2023-02-10 2022-02-15 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 93M 90M 61M 34M 25M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 3M 2M
totalPayables 40M 39M 27M 12M 7M
otherPayables 2M 577 000 0 0 0
accruedExpenses 46M 39M 33M 20M 14M
capitalLeaseObligationsCurrent 2M 0 1M 312 000 0
capitalLeaseObligationsNonCurrent 30M 25M 8M 9M 6M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 981M 917M 820M 508M 467M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP INSP
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-03 2025-08-04 2024-11-04 2024-08-06 2024-05-07 2023-11-07 2023-08-01 2023-05-02 2022-11-01
acceptedDate 2025-11-03 16:07:50 2025-08-04 16:16:57 2025-02-10 16:23:40 2024-11-04 16:18:24 2024-08-06 16:07:03 2024-05-07 16:07:54 2024-02-09 16:02:04 2023-11-07 16:27:48 2023-08-01 16:14:05 2023-05-02 16:06:25 2023-02-10 16:15:32 2022-11-01 16:10:49 2022-02-15 16:07:01 2021-02-23 18:22:59
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 10M -4M 54M 18M 10M -10M -21M -9M -12M -15M -45M -17M -42M -57M
depreciationAndAmortization 4M 3M 7M 2M 1M 839 000 3M 777 000 659 000 593 000 2M 513 000 1M 840 000
deferredIncomeTax 0 0 0 0 0 0 0 -6M 0 0 0 0 0 -22 000
stockBasedCompensation 30M 42M 116M 28M 32M 26M 82M 20M 22M 18M 52M 15M 26M 13M
changeInWorkingCapital 19M -43M -38M 6M -42M -5M -41M -9M -6M -5M -13M 13M -12M -11M
accountsReceivables 30M -45M -3M -10M -8M 19M -30M -8M -5M 1M -27M -8M -9M -12M
inventory -20M -22M -46M -8M -10M -15M -22M -5M -5M -4M 5M 7M -9M -3M
accountsPayables 0 21M 0 2M -9M 4M 9M -707 000 3M 8M 0 5M 0 2M
otherWorkingCapital 9M 3M 11M 22M -15M -12M 2M 5M -92 000 -6M 9M 10M 6M 2M
otherNonCashItems 7M 4M -8M -2M 59M 17M 1M 7M 1M 354 000 15M -268 000 6M 1M
netCashProvidedByOperatingActivities 69M 3M 130M 52M -77 999 9M 25M 4M 5M -1M 12M 11M -20M -53M
investmentsInPropertyPlantAndEquipment -10M -9M -39M -8M -12M -12M -24M -7M -5M -4M -9M -4M -5M -2M
acquisitionsNet 0 0 0 0 0 0 0 0 0 0 0 0 0 -89M
purchasesOfInvestments 0 -94M 0 -226M -56M -56M -281M -137M -250 000 0 0 -250 000 0 -53M
salesMaturitiesOfInvestments 0 149M 0 131M 74M 48M 10M 0 0 0 0 0 0 142M
otherInvestingActivites -1M 0 0 18M -8M -137M 10M 0 0
netCashUsedForInvestingActivites -12M 47M -103M 6M -20M -144M 5M -4M -4M
debtRepayment 0 0 0 0 0 0 0 0 -21M
commonStockIssued 0 5M 14M 9M 4M 4M 0 7M 0
commonStockRepurchased -51M 0 -80M 0 -2M -3M 0 -516 000 0 0 -43 000 0 0 0
dividendsPaid 0 0 0 -6M 0 0 0 0 0
otherFinancingActivites 347 000 -2M -4M 13M -3M -516 000 15M -2M 246M
netCashUsedProvidedByFinancingActivities -51M 4M 10M 7M 768 000 4M 15M 6M 224M
effectOfForexChangesOnCash 115 000 102 000 -118 000 272 000 -10000 -214 000 164 000 -51 000 -2000 6000 75 000 -127 000 -19 000 11 000
netChangeInCash 6M 53M -35M -41M 13M -10M -256M -137M 25M 540 000 227M 231M 24M 168M
cashAtEndOfPeriod 113M 107M 150M 148M 188M 175M 186M 330M 467M 442M 442M 418M 214M 191M
cashAtBeginningOfPeriod 107M 54M 186M 188M 175M 186M 442M 467M 442M 442M 214M 187M 191M 23M
operatingCashFlow 69M 3M 130M 52M -77 999 9M 25M 4M 5M -1M 12M 11M -20M -53M
capitalExpenditure -10M -9M -39M -8M -12M -12M -24M -7M -5M -4M -9M -4M -5M -2M
freeCashFlow 58M -6M 91M 44M -12M -3M 1M -3M 237 000 -5M 2M 7M -25M -56M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-10 2024-02-09 2023-02-10 2022-02-15 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -74M 0 -11M 34M 89M
netCashProvidedByInvestingActivities -113M -295M -20M 29M 87M
netDebtIssuance 0 0 -25M 0 0
longTermNetDebtIssuance 0 0 -25M 0 0
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -80M 0 -43 000 0 125M
netCommonStockIssuance -80M 0 -43 000 0 125M
commonStockIssuance 0 0 0 0 125M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 28M 14M 260M 15M 9M
netCashProvidedByFinancingActivities -52M 14M 235M 15M 134M
incomeTaxesPaid 0 0 0 0 0
interestPaid 22 000 0 2M 2M 0

Earning call transcript

2025 q3
2025-11-04 ET (fiscal 2025 q3)
2025 q2
2025-08-04 ET (fiscal 2025 q2)
2025 q1
2025-05-05 ET (fiscal 2025 q1)
2024 q4
2025-02-10 ET (fiscal 2024 q4)
2024 q3
2024-11-04 ET (fiscal 2024 q3)
2024 q2
2024-08-06 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-02-06 ET (fiscal 2023 q4)
2023 q3
2023-11-08 ET (fiscal 2023 q3)
2023 q2
2023-08-02 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-02-07 ET (fiscal 2022 q4)
2022 q3
2022-11-01 ET (fiscal 2022 q3)
2022 q2
2022-08-02 ET (fiscal 2022 q2)
2022 q1
2022-05-03 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-08-03 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
2026-07-27 ET
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors
2026-07-22 ET
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors 
2026-07-06 ET
Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026
2026-07-06 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026
2026-06-16 ET
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
2026-06-12 ET
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
2026-05-04 ET
Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance
2026-04-29 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
2026-04-06 ET
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
2026-03-03 ET
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
2026-02-14 03:22 ET
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP
2026-02-11 21:02 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
2026-01-12 11:45 ET
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance
2026-01-07 13:00 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
2026-01-05 12:39 ET
Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
2025-12-30 12:39 ET
Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
2025-12-29 13:00 ET
Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-12-29 12:44 ET
Latest SueWallSt Podcast: What INSP Investors Need to Know About the Lawsuit
2025-12-26 12:49 ET
Latest SueWallSt Podcast: What INSP Investors Need to Know About the Lawsuit
2025-12-23 22:15 ET
Shareholders SueWallSt in New Class Action Against Inspire Medical Systems, Inc. - Act Now
2025-12-18 12:44 ET
Latest SueWallSt Podcast: What INSP Investors Need to Know About the Lawsuit
2025-12-17 12:49 ET
Latest SueWallSt Podcast: What INSP Investors Need to Know About the Lawsuit
2025-12-16 12:47 ET
New SueWallSt Podcast Covers Inspire Medical Systems, Inc. (INSP) Class Action
2025-12-15 19:54 ET
Investors SueWallSt as Inspire Medical Systems, Inc. Faces Securities Fraud Allegations
2025-12-15 12:50 ET
Tune Into the SueWallSt Podcast: Inspire Medical Systems, Inc. (INSP) Lawsuit Explained
2025-12-12 12:52 ET
Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
2025-12-08 12:45 ET
SueWallSt Podcast Explains Class Action Against Inspire Medical Systems, Inc. (INSP)
2025-12-05 19:42 ET
Shareholders SueWallSt in New Class Action Against Inspire Medical Systems, Inc. - Act Now
2025-12-04 12:42 ET
New SueWallSt Podcast Covers Inspire Medical Systems, Inc. (INSP) Class Action
2025-12-03 12:57 ET
Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
2025-12-02 12:52 ET
Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
2025-12-01 12:47 ET
SueWallSt Podcast Series Launches With Focus on Inspire Medical Systems, Inc. (INSP) Fraud Allegations
2025-11-24 19:42 ET
Investors SueWallSt as Inspire Medical Systems, Inc. Faces Securities Fraud Allegations
2025-11-19 19:47 ET
Investors SueWallSt as Inspire Medical Systems, Inc. Faces Securities Fraud Allegations
2025-11-18 13:00 ET
Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
2025-11-14 19:47 ET
Investors SueWallSt as Inspire Medical Systems, Inc. Faces Securities Fraud Allegations
2025-11-07 01:51 ET
INSP INVESTOR ALERT: Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead the Inspire Medical Class Action Lawsuit – RGRD Law
2025-11-06 23:48 ET
Grant & Eisenhofer Files Class Action Lawsuit Against Inspire Medical Systems, Inc.
2025-11-03 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook
2025-10-27 ET
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
2025-10-10 ET
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
2025-10-06 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025
2025-08-26 ET
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer
2025-08-20 ET
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
2025-08-11 ET
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program
2025-08-04 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook
2025-07-07 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
2025-06-03 ET
Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference
2025-05-30 ET
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
2025-05-05 ET
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook
2025-04-29 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
2025-04-21 ET
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
2025-04-01 ET
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
2025-03-06 ET
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
2025-02-10 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
2025-01-13 ET
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance
2025-01-07 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2024 Financial Results on February 10, 2025
2024-12-30 ET
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
2024-12-05 ET
Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors
2024-11-19 ET
Inspire Medical Systems, Inc. to Present at Piper Sandler 36th Annual Healthcare Conference
2024-11-15 ET
UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
2024-11-11 ET
Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program
2024-11-06 ET
Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
2024-11-04 21:02 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 Outlook
2024-10-30 12:00 ET
Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference
2024-10-07 12:00 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024
2024-08-21 20:02 ET
Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences
2024-08-06 20:02 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 Outlook
2024-08-06 20:02 ET
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program
2024-08-02 12:00 ET
Inspire Medical Systems, Inc. Announces FDA Approval of the Inspire V System
2024-07-29 10:45 ET
Inspire Medical Systems, Inc. Announces Preliminary Results for Second Quarter of 2024 and Updates 2024 Revenue Outlook
2024-07-23 12:00 ET
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France
2024-07-23 12:00 ET
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France
2024-07-22 12:00 ET
Inspire Medical Systems, Inc. Announces the Appointment of Melissa J. Mann as Chief People Officer
2024-07-19 12:00 ET
Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI Compatibility under the European Union’s Medical Device Regulation
2024-07-19 12:00 ET
Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
2024-07-19 12:00 ET
Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
2024-07-02 12:00 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024
2024-06-04 12:00 ET
Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference
2024-05-23 12:00 ET
Inspire Medical Systems, Inc. to Present at the Jefferies Global Healthcare Conference
2024-05-07 20:02 ET
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook
2024-04-30 12:00 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference
2024-04-02 12:00 ET
Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024
2024-03-05 13:00 ET
Inspire Medical Systems, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
2024-02-06 21:02 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Reaffirms 2024 Outlook
2024-02-05 13:00 ET
Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herbert named Chair and Chief Executive Officer
2024-01-26 13:00 ET
Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. to Retire from its Board after Sixteen Years of Service
2024-01-09 13:00 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2023 Financial Results on February 6, 2024
2024-01-08 13:00 ET
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2023 and Provides Initial 2024 Guidance
2023-12-28 13:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors
2023-12-23 03:03 ET
Saxena White P.A. Files New Securities Fraud Class Action Against Inspire Medical Systems, Inc.
2023-12-18 13:00 ET
Inspire Medical Systems, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-14 13:00 ET
Inspire Medical Systems, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
2023-11-07 21:03 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2023 Financial Results and Updates 2023 Outlook
2023-11-01 12:00 ET
Inspire Medical Systems, Inc. to Present at the Stifel 2023 Healthcare Conference
2023-10-23 12:00 ET
Neuros Medical, Inc. Names David Veino as President and CEO and Expands Board of Directors
2023-10-03 12:00 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2023 Financial Results on November 7, 2023
2023-09-26 12:00 ET
Inspire Medical Systems, Inc. Announces Events at International Surgical Sleep Society and American Academy of Otolaryngology – Head and Neck Surgery Meetings
2023-08-23 12:00 ET
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2023 Healthcare Conference
2023-08-01 20:02 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2023 Financial Results and Updates 2023 Outlook
2023-07-31 12:00 ET
Inspire Medical Systems, Inc. Announces the Addition of Charisse Y. Sparks, M.D. as Chief Medical Officer
2023-07-24 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Carlton Weatherby as Chief Strategy Officer
2023-07-05 12:00 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2023 Financial Results on August 1, 2023
2023-06-09 12:00 ET
Inspire Medical Systems, Inc. Announces FDA Approval for Apnea Hypopnea Index Indication Expansion and Increased Body Mass Index Labeling
2023-06-05 12:00 ET
Inspire Medical Systems, Inc. Announces Events at SLEEP 2023, the 37th Annual Meeting of the Associated Professional Sleep Societies
2023-05-16 12:00 ET
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series
2023-05-03 12:00 ET
UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
2023-05-03 12:00 ET
Inspire Medical Systems, Inc. to Present at the RBC Capital Markets 2023 Global Healthcare Conference
2023-05-02 20:02 ET
Inspire Medical Systems, Inc. Announces First Quarter 2023 Financial Results and Updates 2023 Outlook
2023-04-26 12:00 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
2023-04-04 12:00 ET
Inspire Medical Systems, Inc. to Report First Quarter 2023 Financial Results on May 2, 2023
2023-03-21 12:00 ET
Inspire Medical Systems, Inc. Announces FDA Approval for Pediatric Patients with Down Syndrome
2023-03-09 21:02 ET
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in Belgium
2023-03-09 21:02 ET
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in Belgium
2023-03-07 13:00 ET
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
2023-02-07 21:05 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
2023-01-10 13:00 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2022 Financial Results on February 7, 2023
2023-01-09 13:00 ET
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
2022-12-21 13:00 ET
Inspire Medical Systems, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
2022-12-20 13:00 ET
Inspire Medical Systems, Inc. Publishes Inaugural ESG Summary Report
2022-11-16 13:00 ET
Inspire Medical Systems, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference
2022-11-02 12:00 ET
Inspire Medical Systems, Inc. to Present at the Stifel 2022 Healthcare Conference
2022-11-01 20:02 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2022 Financial Results and Updates 2022 Outlook
2022-10-04 12:00 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2022 Financial Results on November 1, 2022
2022-09-14 12:00 ET
Inspire Medical Systems, Inc. Announces Updates from International Surgical Sleep Society and American Academy of Otolaryngology – Head and Neck Surgery Meetings
2022-08-25 12:00 ET
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2022 Healthcare Conference
2022-08-15 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Ezgi Yagci as Vice President of Investor Relations
2022-08-12 01:41 ET
Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock
2022-08-11 20:35 ET
Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock
2022-08-02 20:05 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2022 Financial Results and Updates 2022 Outlook
2022-08-01 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Two New Independent Directors to its Board
2022-07-06 12:00 ET
Inspire Medical Systems, Inc. Announces FDA Approval of Expanded, Full-Body MRI Compatibility with Inspire Therapy
2022-07-05 12:00 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2022 Financial Results on August 2, 2022
2022-06-06 12:00 ET
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
2022-05-25 12:00 ET
Inspire Medical Systems, Inc. Announces Events at SLEEP 2022, the 36th Annual Meeting of the Associated Professional Sleep Societies
2022-05-11 12:00 ET
Inspire Medical Systems, Inc. to Present at the USB Global Healthcare Conference 2022
2022-05-03 20:05 ET
Inspire Medical Systems, Inc. Announces First Quarter 2022 Financial Results and Updates 2022 Outlook
2022-04-27 21:20 ET
Inspire Medical Systems, Inc. Announces Investments in EnsoData and Ognomy
2022-04-27 12:00 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities 2022 Healthcare Conference
2022-04-05 12:00 ET
Inspire Medical Systems, Inc. to Report First Quarter 2022 Financial Results on May 3, 2022
2022-02-08 21:05 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Guidance
2022-02-07 13:00 ET
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2022 MedTech R&D Spotlight Call Series
2022-02-02 13:00 ET
Inspire Medical Systems, Inc. to Present at the 11th Annual SVB Leerink Global Healthcare Conference
2022-01-05 21:05 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2021 Financial Results on February 8, 2022
2022-01-04 21:05 ET
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2021
2022-01-03 21:05 ET
Inspire Medical Systems, Inc. to Present at the Goldman Sachs Healthcare CEO Conference 2022
2021-12-22 13:00 ET
Inspire Medical Systems, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021-11-17 13:00 ET
Inspire Medical Systems, Inc. to Present at the Piper Sandler 33rd Annual Healthcare Conference
2021-11-10 21:28 ET
Inspire Medical Systems, Inc. Provides Update on 2022 Ambulatory Surgical Center Reimbursement Levels
2021-11-02 20:05 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2021 Financial Results and Updates 2021 Outlook
2021-11-02 12:00 ET
Inspire Medical Systems, Inc. to Present at the Stifel 2021 Virtual Healthcare Conference
2021-10-26 12:00 ET
Inspire Medical Systems, Inc. to Present at the Credit Suisse 30th Annual Healthcare Conference
2021-10-05 12:00 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2021 Financial Results on November 2, 2021
2021-09-15 20:05 ET
Inspire Medical Systems, Inc. Announces Quality Week and Launch of the Patient Experience Report
2021-08-30 22:36 ET
Inspire Medical Systems, Inc. Announces Recommendation by Medicare Panel to Increase Payments for Inspire Therapy to Ambulatory Surgical Centers
2021-08-26 12:00 ET
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2021 Virtual Healthcare Conference
2021-08-03 20:05 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2021 Financial Results and Updates 2021 Outlook
2021-07-06 12:00 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2021 Financial Results on August 3, 2021
2021-05-25 12:00 ET
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
2021-05-20 21:34 ET
Inspire Medical Systems, Inc. Announces Positive Coverage Policy Issued by Anthem for Inspire Therapy
2021-05-04 20:12 ET
Inspire Medical Systems, Inc. Announces First Quarter 2021 Financial Results and Updates 2021 Outlook
2021-04-28 12:00 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference
2021-04-26 06:05 ET
Inspire Medical Systems, Inc. Announces Exclusive Distribution Agreement with Japan Lifeline Co., Ltd to Commercialize Inspire Therapy in Japan
2021-04-06 12:00 ET
Inspire Medical Systems, Inc. to Report First Quarter 2021 Financial Results on May 4, 2021
2021-03-31 20:11 ET
Inspire Medical Systems, Inc. Announces FDA Approval and Commercial Launch of New Physician Programmer Platform
2021-03-15 20:05 ET
Inspire Medical Systems, Inc. Announces FDA Approval of Two-Incision Implant Procedure
2021-02-23 21:05 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Guidance
2021-02-11 13:00 ET
Inspire Medical Systems, Inc. to Present at the 10th Annual SVB Leerink Global Healthcare Conference
2021-01-20 21:05 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2020 Financial Results on February 23, 2021
2021-01-19 21:05 ET
Inspire Medical Systems, Inc. Announces Appointment of Bryan Phillips as General Counsel
2020-12-22 13:00 ET
Inspire Medical Systems, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-11-18 13:00 ET
Inspire Medical Systems, Inc. to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-10 13:00 ET
Inspire Medical Systems, Inc. to Present at the 2020 Stifel Virtual Healthcare Conference
2020-11-09 21:05 ET
Inspire Medical Systems, Inc. Announces Full Integration of Inspire Therapy into German DRG Reimbursement System to Begin in 2021
2020-11-02 21:05 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2020 Financial Results and Updates 2020 Outlook
2020-10-27 20:05 ET
Inspire Medical Systems, Inc. to Present at the Credit Suisse 29th Annual Healthcare Conference
2020-10-22 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Senior Corporate Executive Shelley Broader to its Board of Directors
2020-09-24 12:00 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2020 Financial Results on November 2, 2020
2020-09-02 20:05 ET
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2020 Virtual Healthcare Conference
2020-09-01 11:00 ET
Inspire Medical Systems, Inc. Announces Humana Coverage for Inspire Therapy
2020-08-17 20:05 ET
Inspire Medical Systems, Inc. Announces Two Additional Coverage Policies from Blue Cross Blue Shield Healthcare Plans
2020-08-12 20:05 ET
Inspire Medical Systems, Inc. Announces Regulatory Approval of Inspire Therapy in Australia
2020-08-04 20:05 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2020 Financial Results and Updates 2020 Outlook
2020-07-09 20:05 ET
Inspire Medical Systems, Inc. Announces Appointment of Veteran Consumer Marketing Executive Georgia Garinois-Melenikiotou to its Board of Directors
2020-07-07 12:00 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2020 Financial Results on August 4, 2020
2020-06-16 20:05 ET
Inspire Medical Systems, Inc. Announces Cigna Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea
2020-06-08 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Medical Technology Industry Veteran Phil Ebeling as Chief Operating Officer
2020-06-03 20:05 ET
Inspire Medical Systems, Inc. Introduces Digital Health Tools with Launch of New App
2020-06-01 20:05 ET
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
2020-05-11 11:00 ET
Inspire Medical Systems, Inc. Announces Medicare Policy Release Date of Local Coverage Determination for Sole Remaining Region
2020-05-06 20:05 ET
Inspire Medical Systems, Inc. to Present at the UBS Global Healthcare Conference
2020-05-05 20:10 ET
Inspire Medical Systems, Inc. Announces First Quarter 2020 Financial Results
2020-04-30 20:05 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities Virtual Health Care Conference 2020
2020-04-28 11:00 ET
Inspire Medical Systems, Inc. to Report First Quarter 2020 Financial Results on May 5, 2020
2020-04-21 11:00 ET
Inspire Medical Systems Announces FDA Approval of Expanded Age Range for Inspire Therapy
2020-04-16 20:05 ET
Inspire Medical Systems, Inc. Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
2020-04-14 01:27 ET
Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock
2020-04-13 20:19 ET
Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock
2020-04-13 20:01 ET
Inspire Medical Systems, Inc. Provides First Quarter and Full Year 2020 Update
2020-02-25 21:15 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2019 Financial Results and Provides 2020 Guidance
2020-02-12 21:05 ET
Inspire Medical Systems, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
2020-02-03 21:22 ET
Inspire Medical Systems, Inc. Announces Medicare Policy Release Dates and New Draft Local Coverage Determination for Remaining Region
2020-01-28 21:05 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2019 Financial Results on February 25, 2020
2020-01-07 21:05 ET
Inspire Medical Systems, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-11-20 21:05 ET
Inspire Medical Systems, Inc. to Present at the 31st Annual Piper Jaffray Healthcare Conference
2019-11-06 21:15 ET
Inspire Medical Systems, Inc. to Present at the Stifel 2019 Healthcare Conference
2019-11-05 21:10 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2019 Financial Results and Increases 2019 Outlook

SEC forms

Show financial reports only

SEC form 10
2026-11-02 00:00 ET
Inspire Medical Systems published news for 2026 q3
SEC form 8
2026-11-02 00:00 ET
Inspire Medical Systems published news for 2026 q3
SEC form 8
2026-11-02 00:00 ET
Inspire Medical Systems published news for 2026 q3
SEC form 8
2026-11-02 00:00 ET
Inspire Medical Systems published news for 2026 q3
SEC form 10
2026-08-03 20:07 ET
Inspire Medical Systems published news for 2026 q2
SEC form 8
2026-08-03 20:03 ET
Inspire Medical Systems published news for 2026 q2
SEC form 8
2026-08-03 20:03 ET
Inspire Medical Systems published news for 2026 q2
SEC form 8
2026-08-03 20:03 ET
Inspire Medical Systems published news for 2026 q2
SEC form 8
2026-06-26 10:41 ET
Inspire Medical Systems published news for 2026 q1
SEC form 8
2026-06-26 10:41 ET
Inspire Medical Systems published news for 2026 q1
SEC form 10
2026-05-04 20:07 ET
Inspire Medical Systems published news for 2026 q1
SEC form 8
2026-05-04 20:03 ET
Inspire Medical Systems published news for 2026 q1
SEC form 8
2026-05-04 20:03 ET
Inspire Medical Systems published news for 2026 q1
SEC form 8
2026-05-04 20:03 ET
Inspire Medical Systems published news for 2026 q1
SEC form 10
2026-02-13 21:05 ET
Inspire Medical Systems published news for 2025 q4
SEC form 8
2026-02-11 21:32 ET
Inspire Medical Systems published news for 2025 q4
SEC form 8
2026-02-11 21:32 ET
Inspire Medical Systems published news for 2025 q4
SEC form 8
2026-02-11 21:32 ET
Inspire Medical Systems published news for 2025 q4
SEC form 8
2026-02-11 21:32 ET
Inspire Medical Systems reported for 2025 q4
SEC form 8
2026-02-11 21:32 ET
Inspire Medical Systems published news for 2025 q4
SEC form 8
2026-01-12 22:04 ET
Inspire Medical Systems published news for 2025 q4
SEC form 8
2026-01-12 22:04 ET
Inspire Medical Systems published news for 2025 q4
SEC form 8
2026-01-12 22:04 ET
Inspire Medical Systems published news for 2025 q4
SEC form 10
2025-11-03 16:07 ET
Inspire Medical Systems reported for 2025 q3
SEC form 8
2025-11-03 16:03 ET
Inspire Medical Systems published news for 2025 q3
SEC form 8
2025-11-03 16:03 ET
Inspire Medical Systems reported for 2025 q3
SEC form 8
2025-11-03 16:03 ET
Inspire Medical Systems published news for 2025 q3
SEC form 10
2025-08-04 20:16 ET
Inspire Medical Systems reported for 2025 q2
SEC form 8
2025-08-04 20:10 ET
Inspire Medical Systems published news for 2025 q2
SEC form 8
2025-08-04 20:10 ET
Inspire Medical Systems reported for 2025 q2
SEC form 8
2025-08-04 20:10 ET
Inspire Medical Systems published news for 2025 q2
SEC form 10
2025-05-05 00:00 ET
Inspire Medical Systems published news for 2025 q1
SEC form 8
2025-05-05 00:00 ET
Inspire Medical Systems published news for 2025 q1
SEC form 8
2025-05-05 00:00 ET
Inspire Medical Systems reported for 2025 q1
SEC form 8
2025-05-05 00:00 ET
Inspire Medical Systems published news for 2025 q1
SEC form 10
2025-02-10 16:23 ET
Inspire Medical Systems published news for 2024 q4
SEC form 8
2025-02-10 16:05 ET
Inspire Medical Systems published news for 2024 q4
SEC form 8
2025-02-10 16:05 ET
Inspire Medical Systems reported for 2024 q4
SEC form 8
2025-02-10 16:05 ET
Inspire Medical Systems published news for 2024 q4
SEC form 10
2025-02-10 00:00 ET
Inspire Medical Systems published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Inspire Medical Systems published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Inspire Medical Systems published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Inspire Medical Systems published news for 2024 q4
SEC form 10
2024-11-04 16:18 ET
Inspire Medical Systems reported for 2024 q3
SEC form 8
2024-11-04 16:03 ET
Inspire Medical Systems reported for 2024 q3
SEC form 8
2024-11-04 16:03 ET
Inspire Medical Systems published news for 2024 q3
SEC form 8
2024-11-04 16:03 ET
Inspire Medical Systems published news for 2024 q3
SEC form 10
2024-08-06 16:07 ET
Inspire Medical Systems reported for 2024 q2
SEC form 8
2024-08-06 16:04 ET
Inspire Medical Systems published news for 2024 q2
SEC form 8
2024-08-06 16:04 ET
Inspire Medical Systems reported for 2024 q2
SEC form 8
2024-08-06 16:04 ET
Inspire Medical Systems published news for 2024 q2
SEC form 8
2024-08-06 16:04 ET
Inspire Medical Systems published news for 2024 q2
SEC form 10
2024-08-06 00:00 ET
Inspire Medical Systems published news for 2024 q2
SEC form 8
2024-07-29 00:00 ET
Inspire Medical Systems published news for 2024 q2
SEC form 8
2024-07-29 00:00 ET
Inspire Medical Systems published news for 2024 q2
SEC form 10
2024-05-07 16:07 ET
Inspire Medical Systems published news for 2024 q1
SEC form 8
2024-05-07 16:02 ET
Inspire Medical Systems published news for 2024 q1
SEC form 8
2024-05-07 16:02 ET
Inspire Medical Systems reported for 2024 q1
SEC form 8
2024-05-07 16:02 ET
Inspire Medical Systems published news for 2024 q1
SEC form 10
2024-05-07 00:00 ET
Inspire Medical Systems published news for 2024 q1
SEC form 10
2024-02-09 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-02-06 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-02-06 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-02-06 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 10
2023-11-07 16:27 ET
Inspire Medical Systems published news for 2023 q3
SEC form 8
2023-11-07 16:04 ET
Inspire Medical Systems reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Inspire Medical Systems published news for 2023 q3
SEC form 6
2023-08-02 16:04 ET
Inspire Medical Systems published news for 2023 q2
SEC form 6
2023-08-01 16:57 ET
Inspire Medical Systems published news for 2023 q2
SEC form 10
2023-08-01 16:14 ET
Inspire Medical Systems reported for 2023 q2
SEC form 6
2023-08-01 16:08 ET
Inspire Medical Systems published news for 2023 q2
SEC form 10
2023-08-01 00:00 ET
Inspire Medical Systems published news for 2023 q2
SEC form 8
2023-08-01 00:00 ET
Inspire Medical Systems published news for 2023 q2
SEC form 10
2023-05-02 00:00 ET
Inspire Medical Systems published news for 2023 q1
SEC form 8
2023-05-02 00:00 ET
Inspire Medical Systems reported for 2023 q1
SEC form 10
2023-02-10 16:15 ET
Inspire Medical Systems reported for 2022 q4
SEC form 10
2023-02-10 00:00 ET
Inspire Medical Systems reported for 2022 q4
SEC form 6
2023-02-07 17:17 ET
Inspire Medical Systems published news for 2022 q4
SEC form 6
2023-02-07 16:05 ET
Inspire Medical Systems published news for 2022 q4
SEC form 8
2023-02-07 00:00 ET
Inspire Medical Systems reported for 2022 q4
SEC form 6
2023-01-09 08:14 ET
Inspire Medical Systems published news for 2022 q4
SEC form 6
2023-01-09 08:03 ET
Inspire Medical Systems published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Inspire Medical Systems published news for 2022 q4
SEC form 10
2022-11-01 16:10 ET
Inspire Medical Systems reported for 2022 q3
SEC form 6
2022-11-01 16:04 ET
Inspire Medical Systems published news for 2022 q3
SEC form 10
2022-11-01 00:00 ET
Inspire Medical Systems reported for 2022 q3
SEC form 8
2022-11-01 00:00 ET
Inspire Medical Systems reported for 2022 q3
SEC form 6
2022-08-24 16:16 ET
Inspire Medical Systems published news for 2022 q2
SEC form 6
2022-08-15 16:16 ET
Inspire Medical Systems published news for 2022 q2
SEC form 6
2022-08-04 19:37 ET
Inspire Medical Systems published news for 2022 q2
SEC form 6
2022-08-03 18:29 ET
Inspire Medical Systems published news for 2022 q2
SEC form 10
2022-08-02 16:10 ET
Inspire Medical Systems reported for 2022 q2
SEC form 6
2022-08-02 16:05 ET
Inspire Medical Systems published news for 2022 q2
SEC form 10
2022-08-02 00:00 ET
Inspire Medical Systems reported for 2022 q2
SEC form 8
2022-08-02 00:00 ET
Inspire Medical Systems reported for 2022 q2
SEC form 6
2022-08-01 19:20 ET
Inspire Medical Systems published news for 2022 q2
SEC form 6
2022-06-22 16:03 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-06-08 19:41 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-06-02 20:23 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-10 20:50 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-10 20:46 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-10 20:44 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-03 21:40 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-03 16:08 ET
Inspire Medical Systems published news for 2022 q1
SEC form 10
2022-05-03 16:08 ET
Inspire Medical Systems reported for 2022 q1
SEC form 6
2022-05-03 16:06 ET
Inspire Medical Systems published news for 2022 q1
SEC form 10
2022-05-03 00:00 ET
Inspire Medical Systems reported for 2022 q1
SEC form 8
2022-05-03 00:00 ET
Inspire Medical Systems reported for 2022 q1
SEC form 6
2022-04-12 20:47 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-04-12 20:46 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-04-12 20:45 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-04-12 20:44 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-03-29 20:24 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-03-16 16:31 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:34 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:33 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:32 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:32 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:31 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:30 ET
Inspire Medical Systems published news for 2021 q4
SEC form 10
2022-02-15 16:07 ET
Inspire Medical Systems published news for 2021 q4
SEC form 10
2022-02-15 00:00 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-10 16:03 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-08 16:08 ET
Inspire Medical Systems published news for 2021 q4
SEC form 8
2022-02-08 00:00 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-01-04 16:43 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-01-04 16:07 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2021-11-03 17:12 ET
Inspire Medical Systems published news for 2021 q3
SEC form 10
2021-11-02 16:16 ET
Inspire Medical Systems published news for 2021 q3
SEC form 6
2021-11-02 16:12 ET
Inspire Medical Systems published news for 2021 q3
SEC form 10
2021-11-02 00:00 ET
Inspire Medical Systems published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
Inspire Medical Systems published news for 2021 q3
SEC form 6
2021-08-03 19:21 ET
Inspire Medical Systems published news for 2021 q2
SEC form 10
2021-08-03 16:08 ET
Inspire Medical Systems published news for 2021 q2
SEC form 6
2021-08-03 16:03 ET
Inspire Medical Systems published news for 2021 q2
SEC form 10
2021-08-03 00:00 ET
Inspire Medical Systems published news for 2021 q2
SEC form 8
2021-08-03 00:00 ET
Inspire Medical Systems published news for 2021 q2
SEC form 6
2021-06-07 07:08 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-05-20 17:51 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-05-04 21:55 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-05-04 16:25 ET
Inspire Medical Systems published news for 2021 q1
SEC form 10
2021-05-04 16:14 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-05-04 16:06 ET
Inspire Medical Systems published news for 2021 q1
SEC form 10
2021-05-04 00:00 ET
Inspire Medical Systems published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-03-16 16:30 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2021-02-23 19:39 ET
Inspire Medical Systems published news for 2020 q4
SEC form 10
2021-02-23 18:22 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2021-02-23 16:03 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2021-01-27 16:16 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2021-01-07 16:08 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2020-11-09 16:36 ET
Inspire Medical Systems published news for 2020 q3
SEC form 10
2020-11-02 16:09 ET
Inspire Medical Systems published news for 2020 q3
SEC form 6
2020-11-02 16:05 ET
Inspire Medical Systems published news for 2020 q3
SEC form 6
2020-10-22 16:15 ET
Inspire Medical Systems published news for 2020 q3
SEC form 6
2020-10-22 16:15 ET
Inspire Medical Systems published news for 2020 q3